Roche launches cobas pure integrated solutions analyser to help simplify operations in small to medium sized labs

cobas® pure integrated solutions brings together three diagnostic technologies1 on a single platform to optimise space and resources in small to medium laboratory settings With a footprint of just two square meters, this new analyser provides small to medium sized labs with access to more than 230 diagnostic tests2 across a wide-range of disease areas... Read more

GE Healthcare Unveils Vscan Air, a New Intuitive, Wireless Handheld Ultrasound

At a time when clinicians need quick insights at the point of care, Vscan Air, a pocket-sized ultrasound, enters the market as one of the smallest and lightweight handheld devices without compromising crystal clear image quality and secure data sharing Vscan Air increases access to precise care, helping improve workflow efficiencies and patient outcomes through... Read more

EUROIMMUN Launches Novel Ultrafast Automated Microscope and Intelligent Software for State-of-the-Art Diagnostics

WALTHAM, Mass. – March 16, 2021 – EUROIMMUN, a PerkinElmer, Inc. company, today announced the launch of the EUROPatternTM Microscope Live (EPML) compact immunofluorescence microscope, available with the fourth generation of the Company’s well-established EUROLabOfficeTM 4.0 (ELO 4.0) laboratory management software. The combined system of hardware and software allows for ultrafast automated immunofluorescence image acquisition,... Read more

Roche Annual General Meeting 2021

All proposals of the Board of Directors approved Christoph Franz re-elected as Chairman of the Board of Directors; all current Board members re-elected 34th consecutive dividend increase to CHF 9.10 per share Basel, 16 March 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that its shareholders approved all proposals of the Board of... Read more

Roche launches SARS-CoV-2 variant test to help monitor emerging coronavirus mutations

The cobas SARS-CoV-2 Variant Set 1 Test is designed to detect key spike mutations in virus variants associated with increased human-to-human transmission Accurate detection and differentiation of SARS-CoV-2 mutations can help assess the spread of circulating variants and monitor their potential impact on therapeutics, vaccines and public health interventions Periodic assessments against emerging variants have... Read more

Bio-Techne Announces ISO 9001:2015 Certification for Its Bristol Manufacturing Facility.

MARCH 15, 2021 MINNEAPOLIS, March 15, 2021 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced that its Bristol site in the United Kingdom received ISO 9001:2015 Quality Management Systems certification. Bio-Techne’s Bristol facility produces life science reagents for... Read more

Agilent Announces the 8697 Headspace Sampler with Integrated Intelligence

Integrated technology provides a true system approach to gas chromatography  SANTA CLARA, Calif., March 15, 2021  Agilent Technologies Inc. (NYSE: A) today introduced the Agilent 8697 Headspace Sampler, the first headspace sampler with integrated gas chromatography communication. It marks the expansion of intelligence capability that was first launched with the Agilent Intuvo 9000 GC System in... Read more

Educational Outreach to the Visually Impaired

From scanning electron microscopy data to tactile teaching tools In 2017, Dr. Alex Ball, head of Imaging and Analysis at the Natural History Museum London (NHM), approached ZEISS with an intriguing idea. What if one could take 3D microscopy data sets and create tangible objects using 3D printers? This would create a physical teaching object... Read more

Brooks to Participate in the KeyBanc Life Sciences & MedTech Investor Forum

CHELMSFORD, Mass., March 15, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq:BRKS) announced today that company management will participate in the KeyBanc Life Sciences & MedTech Investor Forum on Tuesday, March 23, 2021 which includes a 35-minute webcast beginning at 1:15 p.m. ET.  The live webcast can be accessed through the Brooks investor relations website at www.brooks.investorroom.com/events. ... Read more

Roche signs definitive merger agreement with GenMark Diagnostics, Inc., to access novel technology to test for broad range of pathogens with one patient sample

Basel, 15 March 2021 Roche to acquire GenMark Diagnostics for US$ 24.05 per share with the expectation to close in the 2nd quarter of 2021 GenMark provides molecular diagnostic tests that are designed to detect multiple pathogens from a single patient sample GenMark’s ePlex platform delivers rapid and actionable results so clinicians can determine the... Read more